Literature DB >> 1657028

Small cell carcinoma of the lung: clinical and biologic aspects.

J Viallet1, D C Ihde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1657028     DOI： 10.1016/1040-8428(91)90002-t

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  6 in total

1.  Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis.

Authors:  M M Hochstenbag; A Twijnstra; J T Wilmink; E F Wouters; G P ten Velde
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

2.  MRI in detection of brain metastases at initial staging of small-cell lung cancer.

Authors:  M van de Pol; A G van Oosterhout; J T Wilmink; G P ten Velde; A Twijnstra
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

3.  Efficacy and safety of prophylactic cranial irradiation in patients with small cell lung cancer.

Authors:  M van de Pol; G P ten Velde; J T Wilmink; A Volovics; A Twijnstra
Journal:  J Neurooncol       Date:  1997-11       Impact factor: 4.130

4.  Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.

Authors:  M van de Pol; A Twijnstra; G P ten Velde; P P Menheere
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Evaluation of neuroendocrine markers in renal cell carcinoma.

Authors:  Hanna Ronkainen; Ylermi Soini; Markku H Vaarala; Saila Kauppila; Pasi Hirvikoski
Journal:  Diagn Pathol       Date:  2010-05-12       Impact factor: 2.644

6.  Aspects of antibody-catalyzed primary amide hydrolysis.

Authors:  R C Titmas; T S Angeles; R Sugasawara; N Aman; M J Darsley; G Blackburn; M T Martin
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.